Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Respiratory Syncytial Virus-Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.

Osei-Yeboah R. et al, (2024), J Infect Dis, 229, S70 - S77

Underreporting and Misclassification of Respiratory Syncytial Virus-Coded Hospitalization Among Adults in Denmark Between 2015-2016 and 2017-2018.

Egeskov-Cavling AM. et al, (2024), J Infect Dis, 229, S78 - S83

AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.

Meeraus W. et al, (2024), J Infect, 88

Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial

Williams LR. et al, (2024)

A phase I double-blind trial investigating trachoma vaccine regimens using the Chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02)

Pollock K., (2024), The Lancet Infectious Diseases

Revaccination with BCG: does it work?

McShane H., (2024), Lancet Infect Dis

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.

Bijukchhe SM. et al, (2024), Vaccine

Apnoea suppresses brain activity in infants

Zandvoort CS. et al, (2024)

A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution

DAKIN S., (2024), Nature Communications

TIRR regulates mRNA export and association with P bodies in response to DNA damage

Glossop MS. et al, (2024)

Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study

Puri A. et al, (2024), Vaccines, 12, 210 - 210

Catalyzing change: Implementing standardised reporting in monogenic inflammatory bowel disease research.

Yeh P-J. et al, (2024), J Pediatr Gastroenterol Nutr

Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disorders.

Shin D. et al, (2024), Cell Stem Cell

RSV and Rhinovirus asymptomatic upper airway infection increases pneumococcal carriage acquisition rates and density in adults whereas nasal inflammation is associated with bacterial shedding

Mitsi E. et al, (2024)

Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases.

Yeoh S. et al, (2024), Pediatr Infect Dis J

Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice.

Clarke MT. et al, (2024), Mol Ther

Efficacy and safety of onasemnogene abeparvovec in children with spinal muscular atrophy type 1: real-world evidence from 6 infusion centres in the United Kingdom

Gowda V. et al, (2024), The Lancet Regional Health - Europe, 37

Evaluation of Acute and Convalescent Antibody Concentration Against Pneumococcal Capsular Polysaccharides for the Diagnosis of Pneumococcal Infection in Children with Community-Acquired Pneumonia

Carter MJ. et al, (2024), Pediatric Infectious Disease Journal, 43, E67 - E70

Oral Valganciclovir Initiated beyond One Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.

Kimberlin DW. et al, (2024), J Pediatr

The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.

Antimicrobial Resistance Collaborators None., (2024), Lancet Glob Health, 12, e201 - e216

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?